Who will buy Alacer, maker of Emergen-C?

Sources close to Nutrition Business Journal suggest that Alacer, the company behind a successful line of effervescent vitamin drink powders, Emergen-C, is on the market with a definitive deal expected within 60 days. Hear Marc Brush, editor-in-chief of NBJ, explain the market and the potential ramifications of the Alacer sale. Merger & acquisition interest from well-heeled investors in pharma and consumer packaged goods remains robust for the supplements industry.